Estimating the health impact and cost-effectiveness of emergency department opt-out testing for blood-borne viruses in Germany
In Germany, an estimated 8,200 individuals were living with undiagnosed HIV in 2023. Late diagnosis (CD4<350) was 52% and 33% of individuals with HIV are diagnosed with advanced disease (1) . Despite progress toward the WHO viral hepatitis elimination goals, a large proportion of infections remain undiagnosed: 85% for hepatitis B (HBV) and 60% for Read More >
Tales from opposite corners of the world: Emergency department opt-out testing: A cost-effective route to earlier HIV and Hepatitis diagnosis in Australia and Germany
Australia and Germany have both made progress toward HIV and viral hepatitis elimination targets, yet a significant share of infections remains undiagnosed. These levels of undiagnosed infection indicate that standard blood-borne virus (BBV) testing approaches are not sufficient to meet public health goals. Emergency department opt-out testing European and US studies demonstrate the cost-effectiveness and Read More >
Publication of our research assessing the potential health and economic benefits of improved management of chronic obstructive pulmonary disease in England, Germany, Canada, and Japan.
Improving the NHS Blood Culture Pathway in England
Bloodstream infections (BSI) are common and cause severe disease and death. Blood cultures are used to identify whether patients have a bacterial or fungal BSI and assess whether the microbe will be resistant to any antimicrobial therapies (AMTs) helping clinicians to prescribe AMTs to patients who truly need them. NHS England’s blood culture audit indicated low adherence to best practice guidelines and trusts have raised concerns regarding the resource implications of achieving compliance.
A cost effectiveness analysis of repeat screening for syphilis in pregnancy as an alternative screening strategy in the UK
Modelling the choice of high-risk human papillomavirus (HR-HPV) assay in the English cervical screening programme
Enabling more efficient patient management of blood stream infections
